Syneos Health, Inc.: A Comprehensive Guide to the Integrated Biopharmaceutical Solutions Company Syneos Health, Inc. is a leading integrated biopharmaceutical solutions company with a strong presence in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. Formerly known as INC Research Holdings, Inc., the company changed its name to Syneos Health, Inc. in January 2018. With a focus on clinical and commercial solutions, Syneos Health offers a range of services to its customers in the biopharmaceutical, biotechnology, and medical device industries. The company operates through two segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers a variety of services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. These services include regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. On the other hand, the Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, such as public relations, advertising, and medical communication; and consulting services. Syneos Health, Inc. has established itself as a major player in the biopharmaceutical solutions space, providing solutions across the entire drug development and commercialization value chain.